Dr. Moshiri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4860 Y St
Sacramento, CA 95817Phone+1 916-734-6074Fax+1 916-734-6197
Education & Training
- Johns Hopkins UniversityResidency, Ophthalmology, 2007 - 2010
- University of Texas Health Science Center at HoustonInternship, Transitional Year, 2006 - 2007
- University of Washington School of MedicineClass of 2006
Certifications & Licensure
- CA State Medical License 2012 - 2025
- MD State Medical License 2010 - 2015
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Ocriplasmin Research to Better Inform Treatment (ORBIT) Start of enrollment: 2014 May 01
Publications & Presentations
PubMed
- 65 citationsNear complete loss of retinal ganglion cells in the math5/brn3b double knockout elicits severe reductions of other cell types during retinal developmentAla Moshiri, Ernesto Gonzalez, Kunifumi Tagawa, Hidetaka Maeda, Minhua Wang
Developmental Biology. 2008-04-15 - 116 citationsPersistent Progenitors at the Retinal Margin of ptc+/- MiceAla Moshiri, Thomas A. Reh
The Journal of Neuroscience. 2004-01-07 - 50 citationsEndophthalmitis following intravitreal injection of anti-VEGF agents: long-term outcomes and the identification of unusual micro-organismsMira M. Sachdeva, Ala Moshiri, Henry A. Leder, Adrienne W. Scott
Journal of Ophthalmic Inflammation and Infection. 2016-01-12
Journal Articles
- A Population Study of Common Ocular Abnormalities in C57BL/6NAla Moshiri, MD, Investigative Ophthalmology and Visual Science
Press Mentions
- Managing Retinal Complications of KProMarch 10th, 2023
- Patterns and Predictors of Successful Treatment Discontinuation in Retinal Vein Occlusions with Macular Edema in the Real WorldFebruary 24th, 2021
- Biallelic UBE4A Loss-of-Function Variants Cause Intellectual Disability and Global Developmental DelayJanuary 8th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: